ps2cdvdc1 31.
file"My Documents/devflow/Scripts/Ps2CDVDCheck 1/PS2CDVDCheck 1_31_FULL_VERSION.rar".
.
.
PS2CDVDCheck 1 31 Full Version.r.
.
.
-i 10.
-i 9.
-i 8.
-i 7.
-i 6.
-i 5.
-i 4.
-i 3.
-i 2.
-i 1.
.
《PS2CDVDCheck》-invalid value (win32 batch).
.
.
.
A:
Try this:
@echo off
Setlocal EnableDelayedExpansion
for /f "tokens=1,2 delims=. " %%a in ('findstr /c:"lzma:[0-9].[0-9]" "c: emp est.rar"') do (
set "rstr=%%a"
)
Note: this works if your ar archive is at the same folder as the batch file, else you should add a path to the archive.
with AGG (where this is not a reflection of chemotherapeutic sensitivity/resistance) ([@B61]). Although these newer assays may be useful in predicting response to chemotherapy, their role in prognosticating outcome remains to be defined. Furthermore, there is currently no specific genetic profile that can guide the use of novel targeted therapies.
Future Directions
=================
Although several targeted therapies have been trialed in TNBC, the response to these drugs has been variable and it remains unclear whether they have any impact on outcome in this disease. Therefore, the use of targeted therapies in TNBC should only be considered as second-line treatment where conventional chemotherapy has failed. However, new strategies are being trialed in order to optimize treatment.
There is currently a need to develop new biomarkers to predict response to targeted therapy and for prognostication. For example, several studies have shown that overexpression of the HER2 receptor predicts response to Herceptin ([@B62]), and it is hoped that HER2-targeted therapies will improve the outcome in patients with HER2-overexpressing tumors. Furthermore, in be359ba680
Related links:
Comments